BRAF and neoplasm: Next-generation sequencing (NGS) analysis detected MSI-H, tumor mutation load (TMB) of 17.06 mutations/Mb, and wild-type status for BRAF/NRAS/KRAS, with mutations in β2M and LRP1B.